Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Net Cash Flow (2022 - 2025)

Praxis Precision Medicines (PRAX) has 4 years of Net Cash Flow data on record, last reported at $207.8 million in Q4 2025.

  • For Q4 2025, Net Cash Flow rose 344.72% year-over-year to $207.8 million; the TTM value through Dec 2025 reached $142.0 million, up 5.88%, while the annual FY2025 figure was $142.0 million, 5.88% up from the prior year.
  • Net Cash Flow reached $207.8 million in Q4 2025 per PRAX's latest filing, up from -$7.9 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $207.8 million in Q4 2025 and bottomed at -$61.4 million in Q1 2022.
  • Average Net Cash Flow over 4 years is $13.6 million, with a median of -$3.8 million recorded in 2022.
  • Peak YoY movement for Net Cash Flow: tumbled 2298.18% in 2023, then surged 344.72% in 2025.
  • A 4-year view of Net Cash Flow shows it stood at -$825000.0 in 2022, then crashed by 2298.18% to -$19.8 million in 2023, then surged by 336.17% to $46.7 million in 2024, then soared by 344.72% to $207.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Cash Flow were $207.8 million in Q4 2025, -$7.9 million in Q3 2025, and -$8.2 million in Q2 2025.